Advancing Access to Diagnostic Innovation essential For AMR Preventio

Not Applicable

• Conditions: Health Condition 1: B99-B99- Other infectious diseases

• Registration Number: CTRI/2020/02/023253
• Lead Sponsor: Foundation for Innovative New Diagnostics

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

A.Patients with fever with no focus / RTI:

a.Children (6 months to <12years) and adolescents (12 years to <18 years old)

b.Presenting with an acute febrile illness defined as temperature of >37.5°C or history of fever within the last 7 days with no focus or suspected RTI.

c.Parent/guardian providing written informed consent for their children if <18 years

d.Obtain assent for adolescents between 12 and < 18 years old

e.Willing to provide blood samples and adhere to study procedures explained in the consent forms following the protocol.

f.Available and willing to return for follow-up visit at the health facility.

B.Training and communication (for those randomised to intervention arm):

a.Parent/guardian providing informed consent to participate in the training and communication component of the study.

b.Clinic staff who have provided written informed consent to participate in the training and communication as per randomisation protocol

Exclusion Criteria

Participants are excluded using the following exclusion criteria:

oChildren and adolescents from 6 months to <18 years old presenting with chronic febrile illness (fever lasting more than 7 days).

oPatients with acute febrile illness outside the allowed age range.

oSeverely ill patients requiring hospital admission or referral as assessed by the study clinicians.

oAnyone refusing consent to the study or not available for follow-up (adults, the children of parents/guardians, or adolescents who refuse or are missed when asking for consent).

Study & Design

• Study Type: Interventional
• Study Design: Not specified